(PTCT) PTC Therapeutics - Performance 55.9% in 12m
PTCT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
4.26%
#30 in Peer-Group
Rel. Strength
87.00%
#999 in Stock-Universe
Total Return 12m
55.87%
#22 in Peer-Group
Total Return 5y
-6.21%
#38 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 7.54 |
| P/E Forward | 6.09 |
| High / Low | USD |
|---|---|
| 52 Week High | 57.17 USD |
| 52 Week Low | 31.00 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 36.29 |
| Buy/Sell Signal +-5 | 1.07 |
| Support / Resistance | Levels |
|---|---|
| Support | 48.3, 35.4 |
| Resistance | 55.3 |
12m Total Return: PTCT (55.9%) vs XBI (-7.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
4.78% | 72% | 82.5% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.68% | -8.84% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.37% | -3.61% | 40.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.33% | 33.2% | -0.68% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
8.13% | -8.29% | 7.01% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
14.7% | 39.8% | -2.94% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.29% | 55.9% | -6.21% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.06% | 28.4% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PTCT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PTCT
| Total Return (including Dividends) | PTCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -4.29% | 3.64% | 4.08% |
| 3 Months | 22.91% | 23.43% | 19.65% |
| 12 Months | 55.87% | -7.41% | 12.88% |
| 5 Years | -6.21% | -20.74% | 113.48% |
| Trend Score (consistency of price movement) | PTCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -87.7% | 30.3% | 86.9% |
| 3 Months | 47.1% | 79.4% | 97.2% |
| 12 Months | 79.8% | -87.3% | 46% |
| 5 Years | -30.1% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th37.00 | -7.66% | -8.04% |
| 3 Month | %th44.50 | -0.42% | 2.72% |
| 12 Month | %th89.00 | 68.34% | 38.08% |
| 5 Years | %th81.00 | 18.33% | -56.07% |
FAQs
Does PTC Therapeutics (PTCT) outperform the market?
Yes,
over the last 12 months PTCT made 55.87%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.41%.
Over the last 3 months PTCT made 22.91%, while XBI made 23.43%.
Performance Comparison PTCT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PTCT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.8% | -8.4% | 4.3% | 43% |
| US NASDAQ 100 | QQQ | 1.1% | -8.4% | 2.9% | 45% |
| German DAX 40 | DAX | -1.3% | -6.2% | -7.8% | 24% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.6% | -9.6% | -0.1% | 35% |
| Hongkong Hang Seng | HSI | 2.1% | -6.8% | -16% | 19% |
| India NIFTY 50 | INDA | 1.9% | -4.3% | 4.8% | 58% |
| Brasil Bovespa | EWZ | 6.3% | -6.2% | -11.8% | 53% |
PTCT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.2% | -6.4% | 0.7% | 33% |
| Consumer Discretionary | XLY | 0.9% | -6.8% | 12% | 39% |
| Consumer Staples | XLP | 2.2% | -4.2% | 5.2% | 48% |
| Energy | XLE | -1% | -9.5% | 10.7% | 53% |
| Financial | XLF | 1.8% | -7.9% | 0.5% | 28% |
| Health Care | XLV | 0.3% | -5.2% | 14.2% | 61% |
| Industrial | XLI | 0% | -9.2% | -2.8% | 30% |
| Materials | XLB | -0.1% | -8.6% | 0.8% | 49% |
| Real Estate | XLRE | 1.4% | -3.7% | 4.9% | 45% |
| Technology | XLK | 0.9% | -11.2% | -0% | 47% |
| Utilities | XLU | 0% | -7.1% | 1.9% | 34% |
| Aerospace & Defense | XAR | 0.5% | -10.8% | -13.9% | 7% |
| Biotech | XBI | -2.8% | -7.9% | 13.9% | 63% |
| Homebuilder | XHB | -2.5% | -12.6% | 8.6% | 50% |
| Retail | XRT | 0.5% | -7.1% | 9.8% | 45% |
PTCT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.7% | -9.58% | 19.2% | 62% |
| Natural Gas | UNG | 4.2% | 3.9% | 32.6% | 61% |
| Gold | GLD | 1.2% | -4.1% | -10.7% | 16% |
| Silver | SLV | 0.2% | -5.9% | -9.5% | 36% |
| Copper | CPER | -8.1% | -17.7% | -16.7% | 33% |
PTCT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.9% | -6% | 8.7% | 58% |
| iShares High Yield Corp. Bond | HYG | 1.2% | -5.5% | 7.7% | 46% |